Opinion
Video
Author(s):
Focusing on the GALAXY arm in the CIRCULATE-Japan study, experts on colorectal cancer discuss how recent data are informing the evolving treatment landscape.
Exploring Unmet Needs to Optimize Neoadjuvant Therapy in Resectable CRC
Lenz Discusses the Prognostic and Predictive Value of HER2 Gene Expression in KRAS Wild-Type mCRC
Longest OS Reported From a Third-Line mCRC Randomized Trial Is Seen in ARC-9 Study
Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting
Murthy Highlights Second-Line Treatment Considerations in ER+/HER2– Metastatic Breast Cancer
OncLive’s June Roundup of Key FDA Approvals in Oncology
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Dr Sabari on Barriers to Biomarker Testing in NSCLC
Dr Backhus on Surgical Eligibility in Borderline Resectable NSCLC
Dr Herbst on the Importance of Multidisciplinary Collaboration in NSCLC